Skip to content
Wednesday 2 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,756.45
-0.30%
DAX
25,839.33
-0.50%
CAC 40
8,280.63
-0.26%
STOXX 50
6,362.15
-0.11%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Thursday 28 January 2021 10:22 am  |  Updated:  Thursday 28 January 2021 10:47 pm

Israeli medtech firm claims it may have found Covid-19 cure

By: Michiel Willems

Add as a preferred source on Google

A new treatment based on proteins could cure people with the Covid-19 virus, an Israeli startup claims.

According to Tel Aviv-based Novel Concepts Medical, the treatment is a combination of natural compounds and was proven in lab results to show a significant decrease in the amount of the Covid-19 ‘spike protein’ within a few hours of incubation.

The company’s founder, Dr. Rachel R. Alkalay, who is a PhD graduate of Queen Mary University London, explained to Morning Wire that the spike protein is the part in the virus that connects the virus to the cell.

“All the research in the world is focused on this spike protein. We managed to decompose it. Essentially, this is the equivalent of taking the fuel out of a car,” Alkalay said.

“We are currently repurposing compounds that have already been tested on millions of people safely for other purposes. Our findings show that it is very possible to have an immediate effect in inhibiting the virus in people who have been exposed,” she added.

Testing

The Novel Concepts Medical formula was tested at the Smart Assays Lab in the Weizmann Science Park in Israel.

Dr Celeste Weiss-Katz, an expert in proteins at Tel Aviv University, confirmed that the lab reports demonstrated that the formula decomposed the Covid-19 spike proteins.

“It is clear to see from the lab results that the Novel Concepts Medical formula causes a significant reduction in the S1 and S2 proteins,” she said.

Alkalay said Novel Concepts Medical is now looking to collaborate with hospitals, both in Israel and other countries, to begin clinical trials.

Read more

Top court ‘opens the floodgates’ for part-time workers’ claims

Supreme Court building under clear sky, symbolizing justice and authority, relevant to recent judicial news coverage

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus

Trending Articles

  • Vodafone and Deliveroo look to patch up Reform ties after Yusuf prison threats

  • Trio of firms poised to quit London Stock Exchange as exodus gathers pace

  • Jaguar reveals the Type 01’s screen-free interior

  • Easyjet’s over-60s recruitment push is economically necessary

  • Jim O’Neill: Capital gains tax hike ‘looms’ as top option for Burnham

More from Morning Wire

  • Top court ‘opens the floodgates’ for part-time workers’ claims

    Lawsuit
    Supreme Court building under clear sky, symbolizing justice and authority, relevant to recent judicial news coverage
  • Gen-Z toymaker Jellycat pursues Home Bargains in latest copyright claim

    Retail
    JellyCat plush toys showcased in a vibrant retail display, highlighting their variety and appeal in the general merchandis...
  • Gradiant Secures Major Water Contract for Hyperscaler AI Data Center Campus in West Texas

    Business Wire
  • UK debt ‘hits £3 trillion’ milestone

    Economics
    Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics
  • ‘Alice in Wonderland’ workspace firm lands £129m Aberdeen-backed finance

    Property
    Modern reception area with unique legs art installation, white desk, and colorful stools.
  • New Drill-Free Treatment Helps Patients to Feel at Ease in the Dentist Chair

    Business Wire
  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
  • The Works activist investor hits back at retailer’s ‘absurd’ claims 

    Retail
    The Works floated in 2018.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook